Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 9/3043% below fair value
$2.33−0.90 (-27.80%)
Close on Nov 13, 2026Market cap $38.27MP/E –Yield –
Sensus Healthcare ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Sensus Healthcare's ebitda for the twelve months ending Jun 30, 2025 was -$1.08M, down 112.4% year over year. For fiscal 2025 it was -$9.91M, down 219.5% from the year before. The highest annual figure on record is $15.15M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.91M | -219.5% |
| FY2024 | Dec 31, 2024 | $8.29M | – |
| FY2023 | Dec 31, 2023 | -$107.00K | -100.7% |
| FY2022 | Dec 31, 2022 | $15.15M | +220.0% |
| FY2021 | Dec 31, 2021 | $4.73M | – |
| FY2020 | Dec 31, 2020 | -$7.51M | – |
| FY2019 | Dec 31, 2019 | -$1.42M | – |
| FY2018 | Dec 31, 2018 | -$1.35M | – |
| FY2017 | Dec 31, 2017 | -$3.33M | – |
| FY2016 | Dec 31, 2016 | -$25.54K | -127.1% |
| FY2015 | Dec 31, 2015 | $94.34K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.09M | -274.6% |
| Q1 FY2026 | Mar 31, 2026 | -$4.26M | -375.3% |
| Q2 FY2025 | Jun 30, 2025 | -$1.84M | -191.6% |
| Q1 FY2025 | Mar 31, 2025 | -$2.56M | -186.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.77M | -68.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.55M | – |
| Q2 FY2024 | Jun 30, 2024 | $2.01M | – |
| Q1 FY2024 | Mar 31, 2024 | $2.96M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.64M | +32.7% |
| Q3 FY2023 | Sep 30, 2023 | -$1.84M | -182.1% |
| Q2 FY2023 | Jun 30, 2023 | -$1.04M | -122.5% |
| Q1 FY2023 | Mar 31, 2023 | -$2.87M | -171.3% |
| Q4 FY2022 | Dec 31, 2022 | $4.25M | -22.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.24M | +594.4% |
| Q2 FY2022 | Jun 30, 2022 | $4.64M | – |
| Q1 FY2022 | Mar 31, 2022 | $4.02M | – |
| Q4 FY2021 | Dec 31, 2021 | $5.46M | +1003.0% |
| Q3 FY2021 | Sep 30, 2021 | $322.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$142.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$907.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $495.00K | -55.6% |
| Q3 FY2020 | Sep 30, 2020 | -$2.10M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.43M | -1324.5% |
| Q1 FY2020 | Mar 31, 2020 | -$3.48M | – |
| Q4 FY2019 | Dec 31, 2019 | $1.11M | +325.4% |
| Q3 FY2019 | Sep 30, 2019 | -$671.17K | – |
| Q2 FY2019 | Jun 30, 2019 | $198.21K | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.06M | – |
| Q4 FY2018 | Dec 31, 2018 | $262.08K | – |
| Q3 FY2018 | Sep 30, 2018 | -$229.44K | – |
| Q2 FY2018 | Jun 30, 2018 | -$365.76K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.01M | – |
| Q4 FY2017 | Dec 31, 2017 | -$306.50K | -392.9% |
| Q3 FY2017 | Sep 30, 2017 | -$862.04K | -2251.8% |
| Q2 FY2017 | Jun 30, 2017 | -$668.46K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.49M | – |
| Q4 FY2016 | Dec 31, 2016 | $104.65K | – |
| Q3 FY2016 | Sep 30, 2016 | $40.06K | – |
See a number that looks wrong?